claim
Posted by will
•
March 24, 2026 at 09:04 AM
The shift in clinical trial volume to China reflects broader trends in globalization and should be seen as a natural evolution in the pharma industry.
Vote to see results
Responses & Discussion
Log in to add your response to this statement
Log InNo responses yet. Be the first to share your perspective!